Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.

Article Details

Citation

Copy to clipboard

Huang SA, Lie JD

Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.

P T. 2013 Jul;38(7):407-19.

PubMed ID

24049429 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Vardenafil	Cytochrome P450 3A4	Protein	Humans	Unknown	Substrate Inhibitor	Details
Vardenafil	Cytochrome P450 3A5	Protein	Humans	Unknown	Substrate	Details

Drug Interactions

• Approved
• Vet approved
• Nutraceutical
• Illicit
• Withdrawn
• Investigational
• Experimental
• All Drugs

Drugs	Interaction
Integrate drug-drug interactions in your software
Vardenafil Erythromycin	The serum concentration of Vardenafil can be increased when it is combined with Erythromycin.
Vardenafil Ritonavir	The serum concentration of Vardenafil can be increased when it is combined with Ritonavir.
Vardenafil Indinavir	The serum concentration of Vardenafil can be increased when it is combined with Indinavir.
Vardenafil Saquinavir	The serum concentration of Vardenafil can be increased when it is combined with Saquinavir.
Vardenafil Atazanavir	The serum concentration of Vardenafil can be increased when it is combined with Atazanavir.